0001225208-16-027957.txt : 20160224 0001225208-16-027957.hdr.sgml : 20160224 20160224165251 ACCESSION NUMBER: 0001225208-16-027957 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160222 FILED AS OF DATE: 20160224 DATE AS OF CHANGE: 20160224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pratt Timothy A. CENTRAL INDEX KEY: 0001432178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 161452656 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2016-02-22 0000885725 BOSTON SCIENTIFIC CORP BSX 0001432178 Pratt Timothy A. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP, GC & Chief Admin Officer Common Stock 2016-02-22 4 A 0 84572.0000 0.0000 A 388348.0000 D Common Stock 2016-02-22 4 F 0 38072.0000 17.2600 D 350276.0000 D Deferred Stock Units 2016-02-22 4 A 0 17381.0000 0.0000 A 2021-02-22 Common Stock 17381.0000 17381.0000 D Performance Share Units 2016-02-22 4 A 0 20012.0000 0.0000 A 2017-12-31 2017-12-31 Common Stock 20012.0000 20012.0000 D Stock Option (Right to Buy) 17.2600 2016-02-22 4 A 0 50590.0000 0.0000 A 2026-02-22 Common Stock 50590.0000 50590.0000 D On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2015 and was subject to the completion of the concurrent three-year individual service period. On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2017. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. /s/ Lee G. Giguere, Attorney-in-Fact 2016-02-24